Assignee
AKIRABIO INC
US·1 granted patent·3 pending applications·1 citations·filing 2021–2024
Top patents by PatentIndex Score
4 records- 0179US11938143B2Compositions comprising 2′-deoxycytidine analogs and use thereof for the treatment of sickle cell disease, thalassemia, and cancersAKIRABIO INC·Filed 2022·Granted Mar 26, 2024·1 cites·20 claims
- 0261US2025000887A1Compositions comprising 2'-deoxycytidine analogs and use thereof for the treatment of sickle cell disease, thalassemia, and cancersAKIRABIO INC·Filed 2024·Application pending·0 cites
- 0351US2023123277A1Compositions comprising 2'-deoxycytidine analogs and use thereof for the treatment of sickle cell disease and thalassemiaAKIRABIO INC·Filed 2022·Application pending·0 cites
- 0442US2023055298A1Compositions comprising 2'-deoxycytidine analogs and use thereof for the treatment of sickle cell disease, thalassemia, and cancersAKIRABIO INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AKIRABIO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →